Ad
related to: Pfizer
Search results
Relay in clinical trial collaboration with Pfizer for breast cancer combo treatment
Seeking Alpha· 2 days agoRelay Therapeutics collaborates with Pfizer to investigate combination therapy for breast cancer using RLY-2608 and atirmociclib. Read more here.
GSK, Pfizer Must Face 75,000 Zantac Cases, Delaware Judge Rules
Bloomberg· 7 days agoGSK Plc and Pfizer Inc. must face about 75,000 Zantac lawsuits filed in state court in Delaware...
A New COVID Booster Targeting JN.1 May Arrive This Fall
Verywell Health via Yahoo News· 14 hours agoAn FDA panel voted to recommend an updated COVID-19 vaccine targeting the JN.1 variant. Here's what...
Relay Therapeutics to Collaborate with Pfizer to Evaluate Breast Cancer Treatment
Morningstar· 2 days agoRelay Therapeutics will collaborate with Pfizer to study atirmociclib in combination with RLY-2608 and fulvestrant in patients with certain types of metastatic breast cancer ...
Paxlovid Doesn't Cure Long COVID
Time via Yahoo News· 13 hours agoPfizer's drug Paxlovid on display in Pembroke Pines, Fla., on July 7, 2022. Credit - Joe Raedle—Getty Images Taking the COVID-19 antiviral Paxlovid does...
Promising Trial Results Show New Standards In Cancer Treatment And Diagnostics Are On The Horizon
Benzinga· 3 days agoOn Friday, Pfizer Inc PFE revealed its drug for an advanced form of lung cancer showed promising...
2 High-Yield Dividend Stocks to Buy Right Now
The Motley Fool via AOL· 3 days agoImage source: Getty Images. Which high-yielders stand out as attractive buys heading into this event? Healthcare titans AbbVie (NYSE: ABBV) and Pfizer...
COVID shots should target JN.1 variant in fall 2024 campaign, US FDA says
Reuters via Yahoo News· 17 hours agoThe Food and Drug Administration's advisory is in line with European and World Health Organization...
US FDA expands GSK’s RSV vaccine approval to adults aged 50 to 59
WSAU Wausau· 9 hours agoBy Sriparna Roy and Christy Santhosh (Reuters) -The U.S. Food and Drug Administration approved the...
Potential Price Increase for Pfizer Inc.
Knox Daily· 5 days agoPfizer Inc.’s filing revealed that its Director Gottlieb Scott acquired Company’s shares for reported $79401.0 on Dec 15 ’23. In the deal valued at $26.47 per share,3,000 ...
